User profiles for Tomoyuki Fujisawa
Tomoyuki Fujisawa浜松医科大学 第二内科 Verified email at hama-med.ac.jp Cited by 6351 |
Regulation of airway MUC5AC expression by IL-1β and IL-17A; the NF-κB paradigm
T Fujisawa, S Velichko, P Thai, LY Hung… - The Journal of …, 2009 - journals.aai.org
Mucin over-production is one of the hallmarks of chronic airway diseases such as chronic
obstructive pulmonary disease, asthma, and cystic fibrosis. NF-κB activation in airway …
obstructive pulmonary disease, asthma, and cystic fibrosis. NF-κB activation in airway …
Cumulative incidence of and predictive factors for lung cancer in IPF
…, T Naito, N Enomoto, D Hashimoto, T Fujisawa… - …, 2009 - Wiley Online Library
Background and objective: Previous studies have indicated a high incidence of lung cancer
in IPF, and some have identified its risk factors. However, those studies were retrospective …
in IPF, and some have identified its risk factors. However, those studies were retrospective …
[HTML][HTML] Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
…, Y Kaida, Y Nakamura, N Enomoto, T Fujisawa… - Respiratory …, 2009 - Elsevier
BACKGROUND: Acute exacerbation (AE) is currently established as a distinct condition
with acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently, …
with acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently, …
Phase relations and volume changes of hafnia under high pressure and high temperature
…, H Fukui, T Kunisada, T Fujisawa… - Journal of the …, 2001 - Wiley Online Library
Using multi‐anvil high‐pressure devices and synchrotron radiation, X‐ray in situ observations
of HfO 2 under high pressure and high temperature have been performed to investigate its …
of HfO 2 under high pressure and high temperature have been performed to investigate its …
Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
T Fujisawa, T Suda, Y Nakamura, N Enomoto… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…
[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease
T Fujisawa, H Hozumi, M Kono, N Enomoto… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
Interstitial lung diseases associated with amyopathic dermatomyositis
T Suda, T Fujisawa, N Enomoto… - European …, 2006 - Eur Respiratory Soc
The aim of the present study was to clarify the clinical characteristics and prognosis of
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…
[HTML][HTML] Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease
H Hozumi, T Fujisawa, R Nakashima, T Johkoh… - Respiratory …, 2016 - Elsevier
Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical phenotypes
in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical features …
in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical features …
Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
…, M Kono, D Hashimoto, N Enomoto, T Fujisawa… - BMJ open, 2013 - bmjopen.bmj.com
Objectives To investigate the risk factors and prognosis associated with acute exacerbation (AE)
in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). …
in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). …
NF-κB Mediates IL-1β– and IL-17A–Induced MUC5B Expression in Airway Epithelial Cells
T Fujisawa, MMJ Chang, S Velichko, P Thai… - American journal of …, 2011 - atsjournals.org
A major pathological feature of chronic airway diseases is the elevated expression of gel-forming
mucins. NF-κB activation in airway epithelial cells has been shown to play a …
mucins. NF-κB activation in airway epithelial cells has been shown to play a …